ArticleAnnals of hematology2025

Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Jun Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.